KRAS and cancer: Tg(5×UAS:EGFP-P2A-krasG12D) harbored a mutated kras gene, krasG12D, one of the most prevalent driver oncogenes in human malignant tumors (Fig. 1A and Table S1) (Schubbert et al., 2007).